Be part of the knowledge.™

ESC Action Center

Welcome to the ESC Action Center, where you’ll find breaking news and insights from the 2024 European Society of Cardiology (ESC) Congress. Explore pivotal presentations, innovative research findings, and emerging treatments to stay at the forefront of the latest advancements in cardiology.

41

LikeLikedUnlike

Episodes 1-15 of 20

Economic burden of CVD in 50 ESC member countries
ESC Action Center
Economic burden of CVD in 50 ESC member countries
- Ramón Luengo-Fernandez, PhD
  Peer
Main messages of the 2024 ESC hypertension guidelines
ESC Action Center
Main messages of the 2024 ESC hypertension guidelines
- Keith Churchwell, MD
  Peer
Optimizing GDMT in HF with digital consults
ESC Action Center
Optimizing GDMT in HF with digital consults
- Mark Schuuring, MD, PhD
  Peer
New ESC Guidelines for CCS and PAAD
ESC Action Center
New ESC Guidelines for CCS and PAAD
- Pierre Sabouret, MD, PhD
  Peer
Continuation or interruption of OAC during TAVI?
ESC Action Center
Continuation or interruption of OAC during TAVI?
- Dirk Jan van Ginkel, MD
  Peer
Effects of empagliflozin on cardiac remodeling post-MI
ESC Action Center
Effects of empagliflozin on cardiac remodeling post-MI
- Jaclyn Carberry, MD
  Peer
Beneficial effects of MRAs in HF across the LVEF spectrum
ESC Action Center
Beneficial effects of MRAs in HF across the LVEF spectrum
- Pardeep Jhund, MD, PhD
  Peer
Effects of empaglifozin on kidney outcomes after acute MI
ESC Action Center
Effects of empaglifozin on kidney outcomes after acute MI
- Deepak Bhatt, MD
  Peer
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
ESC Action Center
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
- C. David Mazer, MD
  Peer
Lp(a) in patients with recent CHD
ESC Action Center
Lp(a) in patients with recent CHD
- Kausik Ray, MBChB, MD, MPhil
  Peer
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
ESC Action Center
Factor XIa inhibitor versus DOAC in patients with AF at high stroke risk
- Manesh R. Patel, MD, FACC, FAHA, FSCAI
  Peer
Predicting 30-year CV outcomes in women
ESC Action Center
Predicting 30-year CV outcomes in women
- Paul Ridker, MD
  Peer
Intensive and early lowering of atherogenic lipids after MI
ESC Action Center
Intensive and early lowering of atherogenic lipids after MI
- Jessica Schubert, MD
  Peer
Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF
ESC Action Center
Class I recommendation to use the AF-CARE pathway in new ESC guidelines for AF
- Isabelle van Gelder, MD, PhD
  Peer
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
ESC Action Center
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
- Scott Solomon, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended